Not Yet RecruitingNot Applicable

Expression of Tim-3 on Neutrophils in Ankylosing Spondylitis

Egypt81 participantsStarted 2026-06-01

Plain-language summary

1. To investigate the expression of Tim-3 on neutrophils in ankylosing spondylitis patients and its correlation with disease activity and inflammatory markers. 2. Association of Tim-3 with sacroiliac MRI findings and the hip inflammatory MRI scoring system (HIMRISS) .

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Adult patients (\>18 years) diagnosed as AS according to 2009 ASAS -Classification criteria (8) Exclusion Criteria:-Age below 18 years old. Patients with other autoimmune diseases. infection (cause increase in inflammatory makers) Any patient with ferromagnetic implants or cardiac pacemaker pregnancy Uncontrolled Hypertension renal failure Chronic liver disease Malignancy Diabetes Mellitus

What they're measuring

To investigate the expression of Tim-3 on neutrophils in ankylosing spondylitis patients

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT07383805

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09-01

Contact for this trial

Eman Safwat, MD

01014116158 safwateman605@gmail.com

View on ClinicalTrials.gov More Ankylosing Spondylitis trials